focus -WSS

focus

author：knowledge 2025-09-02 08:13:40 - browse：397

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Hello, friends! I’m in San Francisco for the STAT Breakthrough Summit. Later today, I’ll be “fireside chatting” with Cytokinetics CEO Robert Blum. It’s not too late to join us virtually. Check out details here.

It’s a travel-shortened week for me, so in this newsletter, I decided to dive deep into PDS Biotech and its experimental drug for head and neck cancer. PDS is what I’d call a biotech cult stock.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： After a decade, new Gardasil ad campaign gets it (mostly) right

WSS

Sanders wants to replace patents with prizes for drug inventions

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Caribou posts encouraging results on off

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

What we know about the American soldier detained in North Korea

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

entertainment

FDA approval of Sarepta Duchenne genetic therapy gives me hope

A Theranos scientist

Anesthesiologist group: stop taking Ozempic before surgery

Sanders wants to replace patents with prizes for drug inventions

The cancer drug shortage isn’t new — and neither are the solutions

Robert Kennedy Jr.'s presidential campaign attracts GOP

Medical leaders decry Supreme Court decision on affirmative action

House passes resolution saying Israel isn't a 'racist or apartheid state'

How to save PrEP access — and even expand it

Manchin plays down potential 3rd

explore

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

There’s a way to spot data fakery. All journals should be using it

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Caribou posts encouraging results on off

More hospitals are billing patients as online messages surge

explore

hotspot

entertainment

leisure time